What does rhIGF stand for?

Recombinant Human Insulin-Like Growth Factor (medical treatment)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Rural Health Implementation Coordination Group (Australian Department of Health and Ageing) Regional Hazardous Inventory Control System Rand Health Insurance Experiment Regional Health Information Exchange (Keystone Health Information Exchange; Danville, PA) Réseau d'Hebergeurs Independants et Engagés (French) Royal Holloway Institute for Environmental Research (UK) Regional Health Insurance Funds (Bulgaria) Relativistic Heavy Ion Group (various universities) Rh Immune Globulin Rural Health Interest Group (University of Wisconsin)		Regal Hotels International Holdings Limited Regional Habitat Importance Index Reproductive Health Integration Initiative (Boston, MA) Robert Half International, Inc. Rental Housing Integrity Improvement Project (United States Department of Housing and Urban Development initiative) Remote Handled Intermediate Level Waste (nuclear industry) Restaurant, Hotel, and Institutional Management Robin Harmia International Ministries (Plant City, FL) Respiratory Health Indicators for Maine (lung health data repository; American Lung Association of Maine) Red Horse Information Management System

Samples in periodicals archive:

These researchers evaluated the use of recombinant human growth hormone (rhGH), recombinant human insulin-like growth factor one (rhIGF-1), or both to increase lean body mass and improve health status in patients with wasting associated with AIDS.

Growth factor therapy not advised for AIDS patients

Long-Term Effect of Recombinant Human Insulin-Like Growth Factor I on Metabolic and Growth Control in a Patient with Leprechaunism.

Insmed Obtains Patent Rights for Extreme Insulin Resistance From ...

3, 2003 Study Shows rhIGFBP-3 Enhances Sensitivity to Herceptin(R) (Trastuzumab) in Models of Herceptin(R) Resistant Breast Cancer Insmed Incorporated (Nasdaq-NMS: INSM) (Nasdaq: INSM) reported today that data from recent studies of the Company's proprietary anti-cancer compound, recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3), will be presented at The 26th Annual San Antonio Breast Cancer Symposium (SABCS), to be held at the Henry B.

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San ...